Rheumatoid arthritis Trials in Baytown, United States
Conditions / Rheumatoid arthritis / Baytown, United States
Clinical trials for Rheumatoid arthritis investigate a range of treatment strategies and patient populations.
13 total trials for this combination
Showing top 10 of 13 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02996500 | Safety and Efficacy of Pf-06650833 In Subjects With Rheumatoid Arthritis, With An Inadequate Response To Methotrexate | COMPLETED | PHASE2 |
| NCT07276581 | A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis | RECRUITING | PHASE2 |
| NCT03120949 | Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis | COMPLETED | PHASE3 |
| NCT02049138 | An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Adults With Rheumatoid Arthritis | COMPLETED | PHASE2 |
| NCT02760433 | Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Were Taking an Existing Medication Called a Tumour Necrosis Factor Alpha Inhibitor But Had Active Disease | COMPLETED | PHASE3 |
| NCT02760407 | Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease | COMPLETED | PHASE3 |
| NCT06902519 | Study of GS-0151 in Participants With Rheumatoid Arthritis | RECRUITING | PHASE1 |
| NCT03915964 | A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis | COMPLETED | PHASE4 |
| NCT05516758 | A Study of Peresolimab (LY3462817) in Participants With Moderately-to-Severely Active Rheumatoid Arthritis | TERMINATED | PHASE2 |
| NCT02990806 | A Phase 3 Study of NI-071 in Participants With Rheumatoid Arthritis (RADIANCE) | COMPLETED | PHASE3 |